Results 141 to 150 of about 13,589 (213)

Addressing the Unmet Educational Needs of Students with Epidermolysis Bullosa in Saudi Arabia. [PDF]

Risk Manag Healthc Policy
Alheggi A, Bin Shlhoob R, Alharthi R, Bukhari A, Alkhodair R.   +4 more
europepmc   +1 more source

Interdisciplinary Approach in Pediatric Patients With Recessive Dystrophic Epidermolysis Bullosa: Experience From the Dermatology Service and the Palliative Care and Complex Chronic Patient Team at Sant Joan de Déu Hospital (Barcelona, Spain). [PDF]

J Eval Clin Pract
Martínez-Ripoll JM, García-Domingo M, De la Fuente Robles YM.   +2 more
europepmc   +1 more source

Oral health status, treatment needs and oral health-related quality of life in patients with epidermolysis bullosa in Austria: a mixed-methods pilot study. [PDF]

Front Oral Health
Véliz S, Strobl S, Haririan H, Manschiebel W, Soare P, Salamon G.   +5 more
europepmc   +1 more source

Case Report: Effective treatment of dystrophic epidermolysis bullosa pruriginosa with tofacitinib. [PDF]

Front Med (Lausanne)
Sun F, Wu Z, Yu Z.
europepmc   +1 more source

A novel bladder phenotype in junctional epidermolysis bullosa: a case report. [PDF]

Front Pediatr
He Q, Gui M, Wang H, Zhang L.
europepmc   +1 more source

Patient-reported outcomes during pregnancy and delivery in epidermolysis bullosa. [PDF]

BMC Pregnancy Childbirth
Zott A, Diem A, Prodinger C, Ude-Schoder K, Bauer JW, Welponer T, Laimer M.   +6 more
europepmc   +1 more source

Epidermolysis Bullosa Simplex with Mottled Pigmentation and Migratory Circinate Erythema: Distinct Subtypes or a Continuum? [PDF]

Acta Derm Venereol
Valinotto LE, Natale M, Lusso SB, Velazquez Perdomo L, Izquierdo A, Andrada R, Cella E, Juana Goitia, Boente MDC, Prado MI, De Freijo S, Manzur G.   +11 more
europepmc   +1 more source

A novel variant c.A527G in <i>ITGB4</i> leads to autosomal dominant epidermolysis bullosa in China. [PDF]

Front Med (Lausanne)
Li J, Yang X, He Y, Cheng P, Li H, Deng A, Wang X, Cai W, Hu J, Tang Q, Gao Y, Hu Y.   +11 more
europepmc   +1 more source

Core outcome domain sets for clinical trials in epidermolysis bullosa - a COSEB protocol to achieve consensus on "what" to measure. [PDF]

Trials
Korte EWH, van den Akker PC, Kiritsi D, Kottner J, Pasmooij AMG, Prinsen CAC, Wally V, Welponer T, Spuls PI, Laimer M, Bolling MC, COSEB Consortium.   +11 more
europepmc   +1 more source

Multicentre phase II open study assessing the efficacy and safety of apremilast in children and adults with epidermolysis bullosa simplex generalised: study protocol for the EBULO study. [PDF]

BMJ Open
Fontas E, Hubiche T, Maruani A, Moschoi R, Hussain S, Chiaverini C.   +5 more
europepmc   +1 more source